Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Application of electron diffraction to rapid structural elucidation of crude reaction products.

Communications chemistry·2026
Same author

Gestational exposure to the artificial sweetener erythritol reprograms ovarian function through AMH suppression and oxidative stress-mediated disruption of autophagy and PI3K signaling.

Frontiers in endocrinology·2026
Same author

Overcoming Biological Barriers and Drug Resistance Through Next-Generation Nanotherapeutic Delivery in Gastric Cancer.

Cells·2026
Same author

Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization.

Biomolecules·2026
Same author

Autophagy-Circulating Tumor DNA Axis in Molecular Cancer Research: Emerging Mechanisms, Therapeutic Targeting, and Translational Opportunities.

International journal of molecular sciences·2026
Same author

Molecular Characterization of Ovarian Endometriosis in Saudi Arabian Women: Insights into Inflammatory, Autophagic, and Epigenetic Dysregulation.

International journal of molecular sciences·2026

相关实验视频

Updated: May 2, 2026

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.1K

采用temozolomide和纳米颗粒载体药物治疗质母细胞瘤的现代方法:组合疗法和治疗的标准护理

Md Ataur Rahman1, Mahesh Kumar Yadab1, Meser M Ali1

  • 1Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI 48201, USA.

Biochemical pharmacology
|August 24, 2025
PubMed
概括

纳米颗粒可增强质母细胞瘤 (GBM) 的提胺 (TMZ) 输送,克服药物耐药性并改善患者的生存率. 这种方法解决了诸如血脑屏障和短半衰期等挑战,

关键词:
血脑屏障药物耐药性质母细胞瘤纳米粒子针对性的治疗泰莫佐洛米德

更多相关视频

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.3K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.8K

相关实验视频

Last Updated: May 2, 2026

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.1K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

18.3K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.8K

科学领域:

  • 神经瘤学
  • 纳米医学
  • 药理学

背景情况:

  • 质母细胞瘤 (GBM) 是一种高度侵袭性的脑瘤,尽管采用了标准治疗,但预后不佳.
  • 泰莫佐洛米德 (TMZ) 是当前的化疗,但它面临的局限性包括血脑屏障 (BBB) 透率低,半衰期短,以及耐药性,特别是通过O6-甲基瓜因-DNA甲基转移酶 (MGMT).

研究的目的:

  • 审查TMZ在GBM治疗中的作用.
  • 探索GBM药物耐药性的机制.
  • 评估纳米技术的潜力,以提高TMZ对GBM的有效性.

主要方法:

  • 对TMZ,GBM,耐药性和基于纳米粒子的药物输送系统的现有文献的审查.
  • 对TMZ的多功能和联合交付系统的分析.
  • 对GBM纳米医学方法的临床前和临床数据的评估.

主要成果:

  • 纳米颗粒为TMZ的局限性提供了解决方案,改善了溶解度,BBB透度,瘤向性和降低毒性.
  • 在临床前和临床研究中,多功能和联合输送纳米载体显示出前景.
  • 基于纳米技术的TMZ治疗代表了GBM治疗的重大进步.

结论:

  • 纳米粒子介导的TMZ是GBM治疗的转型方法.
  • 这种策略具有个性化治疗的潜力, 克服耐药性, 提高患者的生存率.
  • 在将这些先进的纳米药物转化为广泛的临床实践方面仍然存在挑战.